Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non–small cell lung cancer patients
-
Published:2020-08
Issue:4
Volume:44
Page:100540
-
ISSN:0147-0272
-
Container-title:Current Problems in Cancer
-
language:en
-
Short-container-title:Current Problems in Cancer
Author:
Kumar SachinORCID,
Sharawat Surender K.,
Ali Ashraf,
Gaur Vikas,
Malik Prabhat Singh,
Kumar Sunil,
Mohan Anant,
Guleria Randeep
Subject
Cancer Research,Oncology
Reference79 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Lung cancer: New biological insights and recent therapeutic advances;Ramalingam;CA Cancer J Clin,2011
3. New driver mutations in non-small-cell lung cancer;Pao;Lancet Oncol,2011
4. Biomarkers that currently affect clinical practices in lung cancer: EGFR, ALK, MET, ROS-1, and KRAS;Korpanty;Front Oncol,2014
5. MicroRNAs: Genomics, biogenesis, mechanism, and function;Bartel;Cell,2004
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献